International Flavors & Fragrances Inc. · IFF · Next earnings

International Flavors & Fragrances Inc. reports Wednesday, Feb 10, 2027

IFF reports after market close with consensus EPS at $0.75 and revenue at $1.82B. Last quarter: IFF lifts 2026 guidance, but Health & Biosciences remains a pressure point

Reports After market close97 days awayDate estimated Basic Materials

What the street expects

Consensus for the coming report
Consensus EPS $0.75 Calendar consensus
Consensus revenue $1.82B Calendar consensus
Report date Feb 10, 2027 Wednesday, date estimated
Session After market close 97 days away

Where IFF left off: FY2026 Q3

Full report

IFF lifts 2026 guidance, but Health & Biosciences remains a pressure point

EPS surprise +2.1% Reported $0.83 vs $0.81
Revenue surprise +1.8% Reported $1.94B vs $1.91B
Stock move -4.9% Event window
Subsequent drift 0.0% Up to 20 sessions

Raised the low end of full-year 2026 revenue guidance to the stated $7.5–$7.6 billion range and EBITDA guidance to the stated $1.55–$1.60 billion range. Management described the outlook as reflecting growth in Taste and Scent while continuing to address Health & Biosciences softness and input-cost pressure.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Health & Biosciences softness and higher costs could weigh on margins, with Q4 compression specifically flagged in the supplied analysis.
  • Oil-derivative, energy and logistics costs may pressure profitability, and pricing actions may not immediately offset them.
  • The Food Ingredients transaction and stranded-cost reduction require execution; the transaction is not yet closed.
  • Macroeconomic uncertainty and currency volatility may affect demand and reported comparable growth.

Questions analysts left open

  • How quickly Health & Biosciences can turn around.
  • The effect of input-cost inflation and the timing of pricing parity.
  • The degree of Q4 margin compression, particularly in Health & Biosciences.
  • Execution of the Food Ingredients divestiture and stranded-cost reductions.
  • Payables dynamics and working-capital management.

Ask FN2 about IFF next report

Transcript, numbers and history already loaded
What should I watch for in IFF's next earnings report?How did IFF guide last quarter, and is consensus above or below that?Give me the bull and bear case going into IFF earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the IFF recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent IFF quarters

All IFF earnings
-4.9%FY2026 Q3+8.9%FY2026 Q2+17.2%FY2026 Q1+5.9%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.